Perspective Therapeutics, Inc. Financial Ratios — CATX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-45.11	-57.04	-69.15	-40.72	-16.51	-25.4	-45.72	-85.86	-81.12	-51.59	-9.27	-11.3	-68.17	-43.34	-41.44
Return on Assets (%)	-35.91	-45.33	-52.97	-35.47	-14.86	-22.92	-40.58	-67.94	-60.96	-38.03	-8.56	-10.78	-57.3	-36.12	-33.92
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	22.09	13.87	3.32	-4.66	3.63	2.7	17.6	31.1	41.66	52.93	50.94	42.76	- -	- -	- -
EBITDA Margin (%)	-39.6	-54.25	-73.55	-92.5	-81.65	-96.69	-131.09	-112.26	-70.3	-34.39	-32.71	-66.17	- -	- -	- -
Operating Margin (%)	-56.56	-70.95	-89.88	-108.75	-94.16	-106.56	-132.51	-113.61	-72.16	-35.91	-34.19	-68.47	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	310.79	- -	- -
Pretax Margin (%)	-54.25	-68.8	-85.22	-141.24	-79.92	-98.78	-129.43	-113.12	-70.33	-35.6	-33.69	-67.36	- -	- -	- -
Profit Margin (%)	-54.25	-68.8	-85.22	-141.24	-79.92	-98.78	-129.43	-113.12	-70.33	-35.6	-33.69	-67.36	- -	- -	- -
Net Income to Common Margin (%)	-54.45	-69.01	-85.46	-141.49	-80.16	-99.01	-129.66	-113.3	-70.48	-35.71	-33.72	-67.36	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.18	- -	- -	- -	- -
Sustainable Growth Rate (%)	-45.11	-57.04	-69.15	-40.72	-16.51	-25.4	-45.72	-85.86	-81.12	-51.59	-9.29	-11.3	-68.17	-43.34	-41.44

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	3	4	3
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	2	3	3
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.3	-0.24	-0.07	-0.06	-0.06	-0.03
Net Debt/EBITDA	1.02	0.97	0.87	1.97	1.39	2.2	0.95	0.39	1.04	0.72	19.41	7.82	0.19	0.93	0.26
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.29	-0.23	-0.07	-0.06	-0.06	-0.03
Net Debt/EBIT	0.71	0.74	0.71	1.67	1.21	2	0.94	0.39	1.01	0.69	18.57	7.56	0.18	0.9	0.26
EBITDA to Interest Expense	-9.58	-44.6	-475,443.71	-4,419.96	-1,880.5	-4,611	- -	- -	- -	- -	- -	- -	-487.26	-1,343.56	-293.39
EBITDA-CapEx/Interest Expense	-10.3	-46.14	-477,257.14	-4,461.62	-1,955.97	-5,102.54	- -	- -	- -	- -	- -	- -	-500.33	-2,477.19	-327.29
EBIT to Interest Expense	-13.68	-58.33	-581,036.14	-5,196.17	-2,168.5	-5,082	- -	- -	- -	- -	- -	- -	-499.28	-1,391.6	-302.03
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	81.79	77.52	76.06	90.23	90.34	90.6	86.41	67.47	81.51	65.79	95.73	95.09	76.8	85.21	77.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.44	0.78	0.42	3.27	1.05	1.24
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.43	0.77	0.41	3.16	1.04	1.22
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.84	0.74	0.4	2.51	0.9	0.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.56	1.15	0.86	3.39	1.4	1.57
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.94	1.14	0.85	3.28	1.38	1.55
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.55	1.1	0.81	2.61	1.19	1.22
Net Debt to Equity	-32.74	-45.94	-54.04	-32.06	-25.15	-61.82	-55.95	-51.69	-69.35	-41.8	-94.69	-91.21	-9.99	-20.61	-14.01
Net Debt/Capital (%)	-48.67	-84.97	-117.58	-47.19	-33.6	-161.91	-127.02	-107	-226.25	-55.17	-1,465.96	-945.53	-10.97	-25.69	-16.14
EBITDA	-2	-3	-3	-4	-4	-5	-6	-7	-5	-3	-3	-7	-40	-64	-110
EBITDA-CapEx	-2	-3	-3	-4	-4	-5	-7	-7	-6	-4	-4	-7	-41	-119	-123
Operating Income (Loss)	-3	-4	-4	-5	-4	-5	-6	-7	-5	-3	-3	-7	-41	-67	-114

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.73	4.12	3.66	15.32	13.36	11.32	8.11	1.87	4.75	1.52	35.44	24.66	0.59	12.45	5.05
Current Ratio	5.45	6.37	5.6	16.65	14.95	12.46	9.3	2.97	6.53	3.5	37.37	26.18	1.07	12.68	5.17
Quick Ratio	4.3	5.47	4.84	16.16	14.34	11.87	8.83	2.54	5.86	2.84	36.58	25.38	0.66	12.53	5.08
CFO/Avg Current Liab	-2.71	-3.44	-4.24	-3.32	-3.14	-3.55	-5.19	-3.88	-3.42	-2.7	-1.68	-3.79	-4.12	-1.08	-3.52
Common Equity/Total Assets	81.79	77.52	76.06	90.23	90.34	90.6	86.41	67.47	81.51	65.79	95.73	95.09	76.8	85.21	77.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.44	0.78	0.42	3.27	1.05	1.24
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.43	0.77	0.41	3.16	1.04	1.22
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.84	0.74	0.4	2.51	0.9	0.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.56	1.15	0.86	3.39	1.4	1.57
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.94	1.14	0.85	3.28	1.38	1.55
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.55	1.1	0.81	2.61	1.19	1.22
CFO/Total Liabilities	-168.4	-145.07	-180.94	-124.47	-158.57	-228.34	-342.65	-235.55	-289.84	-122.35	-94.25	-243.83	-162.53	-36.27	-137.61
CFO/CapEx	-15.39	-25.69	-240.76	-87.75	-23.33	-7.9	-10.4	-16.95	-11.37	-13.34	-7.45	-28.98	-34.43	-0.34	-6.47
Altman's Z-Score	2.12	1.51	-5.42	36.81	18.56	11.87	3.52	-10.68	-3.55	-6.32	21.86	7.04	-11.79	1.69	-1.04

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	6.2	6.12	5.06	4.59	4.69	5.77	7.15	6.18	6.24	6.05	4.96	5.96	- -	- -	- -
Days Sales Outstanding	58.84	59.66	72.14	79.45	77.74	63.3	51.02	59.1	58.54	60.29	73.65	61.22	- -	- -	- -
Inventory Turnover	5.7	7.32	10.3	11.54	11.63	12.58	11.94	9.99	8.33	7.75	6.07	5.2	- -	- -	- -
Days Inventory Outstanding	64.01	49.9	35.45	31.63	31.4	29.03	30.56	36.54	43.8	47.07	60.13	70.18	- -	- -	- -
Accounts Payable Turnover	- -	20.88	10.55	8.68	8.36	8.23	6.3	4.21	4.15	6.99	7.61	7.78	-0.35	- -	- -
Accounts Payable Turnover Days	- -	17.48	34.58	42.07	43.68	44.34	57.94	86.74	87.96	52.24	47.96	46.93	-1,029.5	- -	- -
Cash Conversion Cycle	122.85	92.08	73.01	69.01	65.46	47.99	23.64	8.89	14.37	55.12	85.82	84.46	- -	- -	- -
Inventory to Cash Days	-5.17	9.77	36.69	47.82	46.34	34.27	20.46	22.56	14.74	13.23	13.52	-8.96	- -	- -	- -
Inventories	1	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	- -	- -
Raw Materials	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	25	31	17	171	81	48	34	25	28	38	113	44	113	225	204
- Cash & Cash Equivalents	2	3	3	8	5	10	6	3	5	2	64	56	9	62	31
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	3	4	3
Enterprise Value	23	29	14	153	67	35	25	22	22	37	50	-11	107	3	63
Total Capital	6	6	5	24	21	16	11	5	8	7	68	62	78	295	210
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.94	1.14	0.85	3.28	1.38	1.55
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03	0.02	-0.05	0.02	1.57	0.05
EV/Sales	4.32	5.64	3.03	36.26	14.49	7.44	5.34	3.7	3.05	3.81	4.99	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	- -
Diluted Market Cap	23	29	17	133	81	48	34	25	27	38	83	44	108	206	203
Diluted Enterprise Value	21	26	14	125	76	38	28	22	22	36	20	-11	101	148	176
EV per Share	8.55	9.24	3.96	27.97	12.15	6.45	4.62	3.89	3.31	5.36	3.54	- -	3.78	0.04	0.85
TTM Sales	5	5	5	4	5	5	5	6	7	10	10	11	- -	- -	- -
TTM EBITDA	-2	-3	-3	-4	-4	-5	-6	-7	-5	-3	-3	-7	-40	-64	-110
TTM Operating Income	-3	-4	-4	-5	-4	-5	-6	-7	-5	-3	-3	-7	-41	-67	-114
TTM Cash Flow to Firm	-2	-2	-3	-3	-4	-4	-6	-6	-5	-4	-3	-8	-37	-18	-82
TTM Free Cash Flow to Firm	-2	-2	-3	-3	-3	-3	-5	-5	-5	-3	-2	-7	-36	36	-69

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-10.39	-12.29	-5.43	-41.72	-24.1	-14.11	-6.66	-4.62	-5.97	-11.16	-33.74	-5.89	-3	5.69	-2.91
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	23	29	14	153	67	35	25	22	22	37	50	-11	107	3	63
Low Price	7.79	3.82	3.5	4.4	12.2	5.5	4.8	3.63	2.69	2.88	3.52	2.52	2.05	2.7	1.6
EV/Sales	4.32	5.64	3.03	36.26	14.49	7.44	5.34	3.7	3.05	3.81	4.99	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-10.39	-6.66	-6.19	-8.33	-26.68	-12.96	-5.63	-3.97	-5.84	-10.71	-26.41	-9.24	-2.53	-9.04	-2.18
Price/Earnings High	-15.24	-13.09	-13.08	-26.95	-56.34	-19.57	-7.93	-5.3	-15.87	-20.73	-86.07	-15.62	-4.2	-15.48	-3.86
Price/Earnings Low	-6.86	-3.12	-3.12	-3.15	-18.14	-6.41	-4.28	-2.98	-3.5	-5.63	-10.78	-4.92	-1.18	-2.19	-1.15
Price/Book Value	3.83	5.37	3.1	7.12	3.91	2.92	3.24	5.04	3.6	6.69	1.68	0.72	1.51	0.78	0.99
Price/Book Value Average	4.83	4.33	4.49	2.66	4.75	3.73	3.28	5.41	3.94	6.59	1.82	1.1	1.65	2.71	1.09
Price/Book Value High	7.09	8.51	9.48	8.61	10.02	5.63	4.62	7.22	10.7	12.76	5.92	1.85	2.74	4.63	1.94
Price/Book Value Low	3.19	2.03	2.26	1	3.23	1.84	2.49	4.07	2.36	3.47	0.74	0.58	0.77	0.66	0.57
Price/Tangible Book Value	3.96	5.57	3.23	7.19	3.95	2.95	3.32	5.25	3.68	6.86	1.68	0.72	148.48	0.94	1.22
Price/Tangible Book Value Average	4.99	4.49	4.67	2.69	4.79	3.76	3.35	5.63	4.03	6.76	1.82	1.1	162.63	3.27	1.35
Price/Tangible Book Value High	7.32	8.82	9.88	8.69	10.12	5.69	4.72	7.52	10.94	13.08	5.93	1.86	269.62	5.59	2.4
Price/Tangible Book Value Low	3.3	2.11	2.35	1.01	3.26	1.86	2.55	4.23	2.41	3.55	0.74	0.59	75.72	0.79	0.71
Price/Sales	4.49	5.7	3.65	31.56	17.63	10.04	7.22	4.19	3.76	3.88	8.24	4.06	- -	- -	- -
Price/Sales Average	5.66	4.6	5.29	11.79	21.39	12.83	7.3	4.5	4.12	3.83	8.91	6.23	- -	- -	- -
Price/Sales High	8.3	9.03	11.18	38.13	45.16	19.38	10.28	6.01	11.18	7.4	29.03	10.52	- -	- -	- -
Price/Sales Low	3.74	2.16	2.66	4.45	14.54	6.34	5.55	3.38	2.47	2.01	3.64	3.31	- -	- -	- -
Price/Cash Flow	-9.71	-11.81	-5.41	-41.24	-23.06	-12.32	-6.02	-4.35	-5.44	-10.32	-29.21	-5.69	-2.91	-11.23	-2.46
Price/Cash Flow Average	-12.25	-9.53	-7.83	-15.41	-27.97	-15.75	-6.09	-4.67	-5.96	-10.17	-31.56	-8.72	-3.19	-39.19	-2.72
Price/Cash Flow High	-17.97	-18.71	-16.56	-49.84	-59.06	-23.8	-8.57	-6.23	-16.2	-19.68	-102.85	-14.73	-5.29	-67.09	-4.82
Price/Cash Flow Low	-8.09	-4.47	-3.94	-5.82	-19.01	-7.79	-4.62	-3.51	-3.57	-5.35	-12.88	-4.64	-1.49	-9.51	-1.43
Price/Free Cash Flow Average	-13.1	-9.91	-7.87	-15.59	-29.22	-18.04	-6.73	-4.96	-6.54	-10.99	-36.45	-9.03	-3.29	19.85	-3.22
Price/Free Cash Flow High	-19.22	-19.47	-16.63	-50.41	-61.7	-27.24	-9.48	-6.62	-17.76	-21.28	-118.81	-15.26	-5.45	33.98	-5.71
Price/Free Cash Flow Low	-8.66	-4.65	-3.96	-5.88	-19.86	-8.92	-5.11	-3.73	-3.92	-5.78	-14.88	-4.81	-1.53	4.82	-1.69
EV/Sales Average	5.55	4.45	4.68	13.29	20.28	10.7	6.06	4.16	3.41	3.76	5.9	1.1	- -	- -	- -
EV/Sales High	8.33	9.24	10.6	47.06	44.08	17.25	9.04	5.7	10.51	7.4	33.4	5.4	- -	- -	- -
EV/Sales Low	3.53	1.8	2.04	3.88	13.42	4.22	4.3	3.01	1.75	1.91	- -	- -	- -	- -	- -
EV/EBITDA Average	-14.01	-8.2	-6.36	-14.37	-24.84	-11.07	-4.62	-3.7	-4.85	-10.92	-18.04	-1.66	-2.94	-11.3	-1.8
EV/EBITDA High	-21.03	-17.03	-14.42	-50.87	-53.99	-17.84	-6.9	-5.07	-14.95	-21.52	-102.11	-8.16	-4.98	-19.98	-3.38
EV/EBITDA Low	-8.91	-3.33	-2.77	-4.2	-16.44	-4.36	-3.28	-2.68	-2.49	-5.54	3.98	2.74	-1.28	-2.07	-0.83
EV/EBIT Average	-9.81	-6.27	-5.21	-12.22	-21.54	-10.04	-4.57	-3.66	-4.72	-10.46	-17.26	-1.61	-2.87	-10.91	-1.75
EV/EBIT High	-14.73	-13.02	-11.8	-43.27	-46.82	-16.19	-6.82	-5.01	-14.57	-20.61	-97.68	-7.88	-4.86	-19.29	-3.29
EV/EBIT Low	-6.24	-2.54	-2.27	-3.57	-14.25	-3.96	-3.25	-2.65	-2.43	-5.31	3.81	2.65	-1.25	-2	-0.81
Last Price	9.35	10.1	4.8	31.2	14.8	8.7	6.25	4.5	4.1	5.56	7.98	3.09	4.02	3.19	2.75
High Price	17.3	16	14.7	37.7	37.9	16.8	8.9	6.45	12.2	10.6	28.1	8	7.3	19.05	5.39
Enterprise Value Average	29	23	21	56	93	51	29	25	25	36	59	12	117	729	199
Enterprise Value High	44	47	48	199	203	82	43	34	77	72	336	58	199	1,289	373
Enterprise Value Low	18	9	9	16	62	20	20	18	13	18	-13	-20	51	133	92

Shares Outstanding	3	3	3	5	5	6	6	6	7	7	14	14	28	71	74
Diluted Weighted Avg Shares	3	3	3	4	5	6	6	6	7	7	10	14	27	64	74
Basic Weighted Avg Shares	3	3	3	4	5	6	6	6	7	7	10	14	27	64	74
Revenue per Share	2.08	1.77	1.31	0.99	0.84	0.87	0.87	1.07	1.09	1.43	0.97	0.76	- -	- -	- -
EBITDA per Share	-0.83	-0.96	-0.97	-0.91	-0.69	-0.84	-1.13	-1.21	-0.77	-0.49	-0.32	-0.5	-1.49	-1	-1.49
Operating Income per Share	-1.18	-1.26	-1.18	-1.08	-0.79	-0.92	-1.15	-1.22	-0.79	-0.51	-0.33	-0.52	-1.53	-1.04	-1.54
Basic EPS, GAAP	-1.14	-1.22	-1.12	-1.4	-0.67	-0.86	-1.12	-1.22	-0.77	-0.51	-0.33	-0.51	-1.74	-1.23	-1.4
Basic EPS from Cont Ops	-1.13	-1.22	-1.12	-1.4	-0.67	-0.86	-1.12	-1.21	-0.77	-0.51	-0.33	-0.51	-1.4	-1.22	-1.4
Diluted EPS, GAAP	-1.14	-1.22	-1.12	-1.4	-0.67	-0.86	-1.12	-1.22	-0.77	-0.51	-0.33	-0.51	-1.74	-1.23	-1.4
Diluted EPS from Cont Ops	-1.13	-1.22	-1.12	-1.4	-0.67	-0.86	-1.12	-1.21	-0.77	-0.51	-0.33	-0.51	-1.4	-1.22	-1.4
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.96	-0.86	-0.89	-0.76	-0.64	-0.71	-1.04	-1.04	-0.75	-0.54	-0.27	-0.54	-1.38	-0.28	-1.12
Free Cash Flow per Basic Share	-1.03	-0.89	-0.89	-0.77	-0.67	-0.8	-1.14	-1.1	-0.82	-0.58	-0.31	-0.56	-1.42	-1.13	-1.29
Cash & Equivalents per Share	0.8	0.86	0.84	3.23	2.65	2.25	1.63	0.61	0.79	0.35	4.5	3.93	0.33	3.21	1.95
Book Value per Share	2.44	1.88	1.55	4.38	3.78	2.98	1.93	0.89	1.14	0.83	4.75	4.31	2.67	4.11	2.78
Tangible Book Value per Share	2.36	1.81	1.49	4.34	3.75	2.95	1.89	0.86	1.12	0.81	4.74	4.31	0.03	3.41	2.25

Perspective Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)